162 related articles for article (PubMed ID: 17147955)
1. Epigenetic processes and cancer risk assessment.
Preston RJ
Mutat Res; 2007 Mar; 616(1-2):7-10. PubMed ID: 17147955
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
[TBL] [Abstract][Full Text] [Related]
5. The dynamic epigenome and its implications in toxicology.
Szyf M
Toxicol Sci; 2007 Nov; 100(1):7-23. PubMed ID: 17675334
[TBL] [Abstract][Full Text] [Related]
6. Cancer susceptibility: epigenetic manifestation of environmental exposures.
Weidman JR; Dolinoy DC; Murphy SK; Jirtle RL
Cancer J; 2007; 13(1):9-16. PubMed ID: 17464241
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of disease: epigenesis.
Waggoner D
Semin Pediatr Neurol; 2007 Mar; 14(1):7-14. PubMed ID: 17331879
[TBL] [Abstract][Full Text] [Related]
8. Maternal care, the epigenome and phenotypic differences in behavior.
Szyf M; Weaver I; Meaney M
Reprod Toxicol; 2007 Jul; 24(1):9-19. PubMed ID: 17561370
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic data and cancer risk assessment: the need for quantitative molecular endpoints.
Preston RJ
Environ Mol Mutagen; 2005; 45(2-3):214-21. PubMed ID: 15645441
[TBL] [Abstract][Full Text] [Related]
10. Histone acetylation and chromatin signature in stem cell identity and cancer.
Shukla V; Vaissière T; Herceg Z
Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic drivers and genetic passengers on the road to cancer.
Sawan C; Vaissière T; Murr R; Herceg Z
Mutat Res; 2008 Jul; 642(1-2):1-13. PubMed ID: 18471836
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
Vaissière T; Sawan C; Herceg Z
Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the epigenetic code of cancer for therapy.
Smith LT; Otterson GA; Plass C
Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.
Tost J
Methods Mol Biol; 2009; 507():3-20. PubMed ID: 18987802
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic control of fetal gene expression.
Nafee TM; Farrell WE; Carroll WD; Fryer AA; Ismail KM
BJOG; 2008 Jan; 115(2):158-68. PubMed ID: 17970798
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic targets in cancer epidemiology.
Dumitrescu RG
Methods Mol Biol; 2009; 471():457-67. PubMed ID: 19109794
[TBL] [Abstract][Full Text] [Related]
17. [DNA methylation analysis in environmental and occupational cancer research].
Baccarelli A; Marinelli B; Bollati V; Albetti B; Consonni D; Bonzini M; Pesatori AC; Bertazzi PA
G Ital Med Lav Ergon; 2005; 27(3):267-71. PubMed ID: 16240570
[TBL] [Abstract][Full Text] [Related]
18. Framework analysis for the carcinogenic mode of action of nitrobenzene.
Hsu CH; Stedeford T; Okochi-Takada E; Ushijima T; Noguchi H; Muro-Cacho C; Holder JW; Banasik M
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(2):155-84. PubMed ID: 17558784
[TBL] [Abstract][Full Text] [Related]
19. [Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development].
Suijkerbuijk KP; van der Wall E; van Laar T; Vooijs M; van Diest PJ
Ned Tijdschr Geneeskd; 2007 Apr; 151(16):907-13. PubMed ID: 17500342
[TBL] [Abstract][Full Text] [Related]
20. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
